000 | 02223 a2200553 4500 | ||
---|---|---|---|
005 | 20250515120404.0 | ||
264 | 0 | _c20080703 | |
008 | 200807s 0 0 eng d | ||
022 | _a1556-1380 | ||
024 | 7 |
_a10.1097/JTO.0b013e31816de276 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJatoi, Aminah | |
245 | 0 | 0 |
_aBortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). _h[electronic resource] |
260 |
_bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _cMay 2008 |
||
300 |
_a516-20 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aBoronic Acids _xadministration & dosage |
650 | 0 | 4 | _aBortezomib |
650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
650 | 0 | 4 |
_aCardia _xpathology |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aEsophagogastric Junction _xpathology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aDakhil, Shaker R | |
700 | 1 | _aFoster, Nathan R | |
700 | 1 | _aMa, Cynthia | |
700 | 1 | _aRowland, Kendrith M | |
700 | 1 | _aMoore, Dennis F | |
700 | 1 | _aJaslowski, Anthony J | |
700 | 1 | _aThomas, Sachdev P | |
700 | 1 | _aHauge, Mark D | |
700 | 1 | _aFlynn, Patrick J | |
700 | 1 | _aStella, Philip J | |
700 | 1 | _aAlberts, Steven R | |
773 | 0 |
_tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _gvol. 3 _gno. 5 _gp. 516-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/JTO.0b013e31816de276 _zAvailable from publisher's website |
999 |
_c17945345 _d17945345 |